The identified surrogate biomarkers that determine ctDNA in this post hoc analysis are tumor size, %Ki-67 positive in breast cancer, PET FDG SUV in lung cancer, and depth of microinvasion in colorectal cancer. This evidence concerns the gene MKI67 and lung cancer.